首页> 外文期刊>Genetic Testing >A Simple Multiplex Real-Time PCR Methodology for the SMN1 Gene Copy Number Quantification
【24h】

A Simple Multiplex Real-Time PCR Methodology for the SMN1 Gene Copy Number Quantification

机译:SMN1基因拷贝数定量的简单多重实时PCR方法

获取原文
获取原文并翻译 | 示例
       

摘要

Spinal muscular atrophy (SMA) is an autosomal recessive disease caused, in about 95% of SMA cases, by ho-mozygous deletion of the survival motor neuron 1 (SMN1) gene or its conversion to the highly homologous SMN2 gene. The molecular diagnosis of SMA is usually carried out by a PCR-Restriction fragment length polymorphism (RFLP) approach. However, this approach is not useful for identification of healthy deletion carriers. TaqMan technology is one of the most reliable and widely adopted techniques for the SMN1 copy number evaluation. However, several limitations of this technique have been described. Particularly, DNA extraction methods and accurate template quantification have been shown to be critical for reliable results. In this work, we set up a reliable, highly reproducible, and easy-to-perform TaqMan technology-based protocol to obtain the SMN1 gene copy number assessment. We demonstrate that PCR amplification of both target gene and reference gene in the same reaction mix, instead of separated mixes, greatly reduces reported criticisms of simplex TaqMan technology. The multiplex real-time PCR we describe allows interlaboratory samples and data exchange, without the need to equalize the DNA isolation technique. Further, the protocol described below requires fewer replica tests than the simplex methodology does, leading to reduced overall cost for the diagnostic assay.
机译:脊髓性肌萎缩症(SMA)是一种常染色体隐性遗传疾病,在约95%的SMA病例中,是由生存运动神经元1(SMN1)基因的纯合缺失或其向高度同源SMN2基因的转化引起的。 SMA的分子诊断通常通过PCR限制性片段长度多态性(RFLP)方法进行。但是,这种方法对于健康删除载体的识别没有用。 TaqMan技术是用于SMN1拷贝数评估的最可靠和广泛采用的技术之一。但是,已经描述了该技术的一些局限性。特别是,DNA提取方法和准确的模板定量已显示出对于可靠结果至关重要。在这项工作中,我们建立了一个可靠的,高度可重复的和易于执行的基于TaqMan技术的协议,以获取SMN1基因拷贝数评估。我们证明,在同一反应混合物中而不是在分离的混合物中,靶基因和参考基因的PCR扩增极大地减少了报道的对单纯TaqMan技术的批评。我们描述的多重实时PCR允许实验室间的样品和数据交换,而无需均衡DNA分离技术。此外,与单纯形方法相比,下面描述的协议所需的复制品测试更少,从而降低了诊断测定的总体成本。

著录项

  • 来源
    《Genetic Testing》 |2009年第1期|37-42|共6页
  • 作者单位

    Dipartimento di Scienze e Tecnologie Biomediche University of Udine P.le Massimiliano Kolbe 2 33100 Udine Italy;

    Dipartimento di Scienze e Tecnologie Biomediche University of Udine P.le Massimiliano Kolbe 2 33100 Udine Italy;

    Dipartimento di Scienze e Tecnologie Biomediche University of Udine P.le Massimiliano Kolbe 2 33100 Udine Italy;

    Dipartimento di Scienze e Tecnologie Biomediche University of Udine P.le Massimiliano Kolbe 2 33100 Udine Italy;

    U.O. di Biochimica e Genetica, Istituto Neurologico 'C. Besta,' Milano, Italy;

    Dipartimento di Scienze e Tecnologie Biomediche University of Udine P.le Massimiliano Kolbe 2 33100 Udine Italy;

    Dipartimento di Scienze e Tecnologie Biomediche University of Udine P.le Massimiliano Kolbe 2 33100 Udine Italy;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:21:22

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号